Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Southern California
Individuals with suspected acute HIV infection willing to start immediate ART treatment will be given the ART regimen (bictegravir 50mg + tenofovir alafenamide 25 mg + emtricitabine 200 mg fixed dose combination) on the day of diagnosis. Those patients beginning immediate ART in the ED who are willing to have additional laboratory specimens drawn in the ED and become part of a cohort to receive ART and have ongoing biological specimens obtained and will be followed for 48 weeks.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Suspected acute HIV infection
agree to start immediate ART and to storage of laboratory specimens
You may not be if
Known chronic HIV infection
severe renal or liver disease
drug allergy/hypersensitivity
prohibited medications
pregnancy
co-morbidity that the investigator feels would compromise safety, data interpretation, or achieving study objectives
